nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

15.08.2017 | Case Report

Hemostatic Radiotherapy Used Twice for Inoperable Progressive Gastric Cancer with Bleeding

verfasst von: Osamu Tanaka, Kana Matsuura, Akihiko Sugiyama, Tomohiro Kato, Eiichi Tomita, Masayuki Matsuo

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Both men and women suffer from high morbidity as a result of gastric cancer in Asian countries, including Japan. The first choice of treatment of gastric cancer without distant metastasis is surgery, and adjuvant chemotherapy is performed in stage II and stage III. …

Hashimoto K, Mayahara H, Takashima A, et al. Palliative radiation therapy for hemorrhage of unresectable gastric cancer: a single institute experience. J Cancer Res Clin Oncol. 2009;135:1117–23.CrossRefPubMed

Lee JA, do Lim H, Park W, et al. Radiation therapy for gastric cancer bleeding. Tumori. 2009;95:726–30.CrossRefPubMed

Asakura H, Hashimoto T, Harada H, et al. Palliative radiotherapy for bleeding from advanced gastric cancer: is a schedule of 30 Gy in 10 fractions adequate? J Cancer Res Clin Oncol. 2011;137:125–30.CrossRefPubMed

Nakanowatari M, Ozaki S, Fukuhara T, et al. A case of unresectable advanced gastric cancer treated with palliative radiation therapy twice for the purpose of hemostatis. Palliative Care Res. 2013;8:538–43. (in Japanese)CrossRef

Hiramoto S, Kikuchi A, Yoshioka A, et al. Efficacy of palliative radiation for advanced gastric cancer patients. Palliative Care Res. 2015;10:10514–7. (in Japanese)CrossRef

Chaw CL, Niblock PG, Chaw CS, et al. The role of palliative radiotherapy for hemostasis in unresectable gastric cancer: a single-institution experience. Ecancermedicalscience. 2014;8:384.PubMedPubMedCentral

Titel: Hemostatic Radiotherapy Used Twice for Inoperable Progressive Gastric Cancer with Bleeding
verfasst von: Osamu Tanaka
Kana Matsuura
Akihiko Sugiyama
Tomohiro Kato
Eiichi Tomita
Masayuki Matsuo
Publikationsdatum: 15.08.2017
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2019
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-017-9994-x

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Hemostatic Radiotherapy Used Twice for Inoperable Progressive Gastric Cancer with Bleeding

Excerpt

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Is It Possible a Conservative Approach After Radiochemotherapy in Locally Advanced Rectal Cancer (LARC)? A Systematic Review of the Literature and Meta-analysis

Music Is Capable of Inducing Changes in Gene Expression in Gastric Cancer Cells

Hepatocellular Carcinoma Surveillance—Experience from Croatian Referral Centre for Chronic Liver Diseases

Regulatory Fluctuation of WNT16 Gene Expression Is Associated with Human Gastric Adenocarcinoma

Differential Diagnosis of Pancreatic Epidermoid Cyst Without a Solid Component (Residual Splenic Tissue) vs. Mucinous Cystic Neoplasm

Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie